Literature DB >> 21695703

Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-β1.

Xiaoming Lu1, Jun Liu, Hang Li, Wei Li, Xuesong Wang, Jingwei Ma, Qiang Tong, Ke Wu, Guobin Wang.   

Abstract

BACKGROUND AND OBJECTIVES: Regulatory T cells (Treg) inhibits immune responses mediated by T cells. This study aimed to investigate whether Treg are accumulated in human gastric cancer tissue and the mechanism of Treg induction by gastric cancer cells.
METHODS: Tissue infiltrated leukocytes from gastric adenocarcinomas were subjected to flow cytometry and immunohistochemistry. Percentage, phenotype, function, and clinical relevance of Treg were analyzed. TGF-β1 production by cancer cells was determined by Western blot and in vitro co-culture experiments were performed to mimic gastric cancer microenvironment.
RESULTS: The percentages of CD4(+) Foxp3(+) T cells in gastric cancer tissues were significantly higher than those from adjacent non-tumor gastric tissues (P < 0.05). The results of classical Treg phenotype and proliferation assay supported that the elevated CD4(+) Foxp3(+) T cells represents a suppressive Treg population. High proportion of Treg is correlated to advance TNM stage and reduced survival. Primary gastric cancer cells produced abundance of TGF-β1 which was responsible for conversion of Treg.
CONCLUSION: The proportion of functional Treg is elevated in human gastric cancer and related to poor prognosis. Gastric cancer cells directly convert CD4(+) naive T cells to Treg by TGF-β1, suggesting a possible mechanism through which tumor cells evade the immune system.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21695703     DOI: 10.1002/jso.22005

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  18 in total

1.  Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients.

Authors:  Audrey Hennequin; Valentin Derangère; Romain Boidot; Lionel Apetoh; Julie Vincent; David Orry; Jean Fraisse; Sylvain Causeret; François Martin; Laurent Arnould; Françoise Beltjens; François Ghiringhelli; Sylvain Ladoire
Journal:  Oncoimmunology       Date:  2015-06-03       Impact factor: 8.110

2.  C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer.

Authors:  Songyang Wu; Hongyong He; Hao Liu; Yifan Cao; Rochen Li; Heng Zhang; He Li; Zhenbin Shen; Jing Qin; Jiejie Xu
Journal:  Oncoimmunology       Date:  2018-03-06       Impact factor: 8.110

Review 3.  Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.

Authors:  Alicia Cristina Peña-Romero; Esteban Orenes-Piñero
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

Review 4.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

5.  Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.

Authors:  Yiting Geng; Hui Wang; Changqing Lu; Qing Li; Bin Xu; Jingting Jiang; Changping Wu
Journal:  Int J Clin Oncol       Date:  2014-05-09       Impact factor: 3.402

6.  HER2 mRNA status contributes to the discrepancy between gene amplification and protein overexpression in gastric cancer.

Authors:  Gui-Fen Ma; Yi-Mei Liu; Hong Gao; Qing Miao; Tian-Cheng Luo; Xiao-Qing Zeng; Shi-Yao Chen
Journal:  Dig Dis Sci       Date:  2013-11-02       Impact factor: 3.199

7.  Transforming growth factor-β1 and -β2 in gastric precancer and cancer and roles in tumor-cell interactions with peripheral blood mononuclear cells in vitro.

Authors:  Gui-Fen Ma; Qing Miao; Xiao-Qing Zeng; Tian-Cheng Luo; Li-Li Ma; Yi-Mei Liu; Jing-Jing Lian; Hong Gao; Shi-Yao Chen
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

8.  Immunotherapy: shifting the balance of cell-mediated immunity and suppression in human prostate cancer.

Authors:  Jo A Tucker; Caroline Jochems; James L Gulley; Jeffrey Schlom; Kwong Y Tsang
Journal:  Cancers (Basel)       Date:  2012-12-11       Impact factor: 6.639

9.  High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment.

Authors:  G-F Ma; Q Miao; Y-M Liu; H Gao; J-J Lian; Y-N Wang; X-Q Zeng; T-C Luo; L-L Ma; Z-B Shen; Y-H Sun; S-Y Chen
Journal:  Br J Cancer       Date:  2014-02-18       Impact factor: 7.640

10.  Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: a meta analysis.

Authors:  Yong Huang; Huaiwei Liao; Yong Zhang; Rongfa Yuan; Fengmei Wang; Yingtang Gao; Peng Wang; Zhi Du
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.